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Catheter-associated urinary tract infection (CAUTI) is the most common nosocomial infection in the United
States. Uropathogenic Escherichia coli (UPEC), the most common cause of CAUTI, can form biofilms on
indwelling catheters. Here, we identify and characterize novel factors that affect biofilm formation by UPEC
strains that cause CAUTI. Sixty-five CAUTI UPEC isolates were characterized for phenotypic markers of
urovirulence, including agglutination and biofilm formation. One isolate, E. coli MS2027, was uniquely
proficient at biofilm growth despite the absence of adhesins known to promote this phenotype. Mini-Tn5
mutagenesis of E. coli MS2027 identified several mutants with altered biofilm growth. Mutants containing
insertions in genes involved in O antigen synthesis (rmlC and manB) and capsule synthesis (kpsM) possessed
enhanced biofilm phenotypes. Three independent mutants deficient in biofilm growth contained an insertion
in a gene locus homologous to the type 3 chaperone-usher class fimbrial genes of Klebsiella pneumoniae. These
type 3 fimbrial genes (mrkABCDF), which were located on a conjugative plasmid, were cloned from E. coli
MS2027 and could complement the biofilm-deficient transconjugants when reintroduced on a plasmid. Primers
targeting the mrkB chaperone-encoding gene revealed its presence in CAUTI strains of Citrobacter koseri,
Citrobacter freundii, Klebsiella pneumoniae, and Klebsiella oxytoca. All of these mrkB-positive strains caused type
3 fimbria-specific agglutination of tannic acid-treated red blood cells. This is the first description of type 3
fimbriae in E. coli, C. koseri, and C. freundii. Our data suggest that type 3 fimbriae may contribute to biofilm
formation by different gram-negative nosocomial pathogens.
Catheter-associated urinary tract infection (CAUTI) is the
most common nosocomial infection in the United States,
where it accounts for approximately 40% of all nosocomial
infections (49). Although CAUTI is usually asymptomatic, it is
a frequent cause of bacteremia and infected patients can also
experience fever, acute pyelonephritis, and death (59). The risk
of bacteriuria following urethral catheterization is estimated to
be 5 to 10% per day (60). Most patients with indwelling urinary
catheters for 30 days or longer develop bacteriuria (49).
Nosocomial CAUTI is caused by a range of gram-negative
and gram-positive organisms, including Escherichia coli, Pro-
teus mirabilis, Pseudomonas aeruginosa, Providencia stuartii,
Staphylococcus epidermidis, and Enterococcus faecalis (60).
These infections are often polymicrobial and can last from
several days to months (29). E. coli is one of the most common
organisms isolated from the urine of CAUTI patients. Like
uropathogenic E. coli (UPEC) strains that cause cystitis and
pyelonephritis, CAUTI E. coli strains possess a range of viru-
lence factors, including adhesins (e.g., P and type 1 fimbriae)
and toxins (e.g., hemolysin), and express certain O antigen and
capsule (K) types (29). Adherence is important for the colo-
nization of the urinary tract, and the best-characterized ad-
hesins of UPEC are P and type 1 fimbriae from the chaperone-
usher subclass. P fimbriae are associated most strongly with
pyelonephritis and contribute to the establishment of bacteri-
uria by binding to the -D-galactopyranosyl-(1-4)--D-galacto-
pyranoside receptor epitope in the globoseries of glycolipids
(22, 27). Type 1 fimbriae are produced by most E. coli strains
and contribute to the colonization of the bladder by binding to
-D-mannosylated proteins, such as uroplakins (62). Both P
and type 1 fimbriae recognize their receptor targets by virtue of
organelle tip-located adhesins, namely PapG and FimH, re-
spectively (25).
CAUTI results from the growth of bacterial biofilms on the
inner surface of the urinary catheter. Biofilm formation pro-
motes encrustation and protects bacteria from the hydrody-
namic forces of urine flow, host defenses, and antibiotics (58).
The removal and replacement of the infected catheter is often
the only option for patients with symptomatic CAUTI. Treat-
ment with antibiotics is thought to merely postpone the onset
of bacteriuria and may result in the emergence of resistant
bacteria in the patient and in the medical unit (58). Indeed, in
intensive care units, CAUTI can be caused by bacteria that are
resistant to all known antibiotics (34).
The mechanisms by which CAUTI E. coli strains adhere to
and form biofilms on the surfaces of urinary catheters have not
been well described. Several different factors have been asso-
ciated with biofilm formation by E. coli, including type 1 and
F9 fimbriae, flagella, curli, and antigen 43 (24, 29, 37, 38, 53).
Here we examined in detail the biofilm-forming properties of
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the E. coli strain MS2027, which was isolated from a patient
with nosocomial CAUTI. Genes associated with the formation
of O antigen, capsule, and type 3 fimbriae were found to
influence biofilm growth. This is the first report to describe the
production and functional role of type 3 fimbriae in E. coli.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The strains and plasmids
used in this study are described in Table 1. Clinical UTI isolates were obtained
from urine samples of patients at the Princess Alexandra Hospital (Brisbane,
Australia). The E. coli reference (ECOR) collection was obtained from the
STEC Center, Michigan State University. E. coli MS427 (MG1655 flu) and E.
coli MS528 (MG1655 fim flu) have previously been described (23, 37). E. coli
MS661 is E. coli MS427 recA::tet. E. coli MS1355 is a spontaneous rifampin-
resistant mutant of E. coli MS2027. Cells were routinely grown at 37°C on solid
or in liquid Luria-Bertani (LB) medium supplemented with appropriate anti-
biotics unless otherwise stated. M9 minimal medium consisted of 42 mM
Na2HPO4, 22 mM KH2O4, 9 mM NaCl, 18 mM NH4Cl, 1 mM MgSO4, 0.1 mM
CaCl2, and 0.2% glucose (41) supplemented with appropriate antibiotics.
DNA manipulations and genetic techniques. Plasmid DNA was isolated by
using the QIAprep Spin Miniprep kit (Qiagen, Australia). Restriction endo-
nucleases were used according to the manufacturer’s specifications (New En-
gland Biolabs). Chromosomal DNA was purified by using the GenomicPrep cell
and tissue DNA isolation kit (Amersham Pharmacia Biotech, Inc., Australia).
PCR was performed by using the Expand Long Template PCR system (for
amplification of the mrk gene cluster) or Taq polymerase (for screening assays)
according to the manufacturer’s instructions (Roche, Australia). DNA sequenc-
ing was performed by the Australian Genome Research Facility. The mrk gene
cluster was amplified from E. coli MS2027 by PCR using primers 871 (5-CGC
GCGATATCGCAGCATAACCGAACAAATG) and 872 (5-CCGGGGATAT
CTAAATTTTCTGCGGCAAACC). The PCR product was digested with
EcoRV and ligated to the EcoRV-digested plasmid pBR322 to construct plasmid
pCO12.
Phenotypic assays. Type 1 fimbria expression was assayed by the ability of
bacterial cells to cause mannose-sensitive (MS) agglutination of yeast (Saccharo-
myces cerevisiae) cells on glass slides (46). Bacterial strains were grown overnight
as shaking cultures in LB broth. Those strains with negative results by this assay
were retested after three successive rounds of 48 h of static growth in LB broth.
Mannose-resistant (MR) agglutination was assessed as described previously (15).
Briefly, a 5% suspension (10 l) of human type A red blood cells (RBC) washed
in phosphate-buffered saline (PBS) was mixed with a 10-l bacterial suspension
on glass slides in the presence and in the absence of D-mannose. The bacterial
suspension was prepared by transferring cells from a freshly grown LB agar
colony into 50 l PBS. Bacterial agglutination of tannic acid-treated human RBC
(MR/K agglutination) was performed as described previously (10). Curli pro-
duction was detected by the ability of colonies to stain with Congo red (63).
Transposon mutagenesis. Transposon mutagenesis was performed via filter
paper bacterial conjugation (7, 9). An overnight culture of the donor strain was
concentrated 10-fold and left to stand at 37°C for 30 min to allow growth of the
sex pili. The donor and recipient were then mixed in a ratio of 1:10 and left to
incubate on filter paper for 3 to 4 h. The filter paper mixture was then resus-
pended in LB and plated out on selective antibiotic medium. Colonies confirmed
as kanamycin resistant and ampicillin sensitive were tested for biofilm growth in
the microtiter assay. Transposon insertion sites of transconjugants with altered
biofilm abilities were identified by using inverse PCR as described previously
(57). Primers 390 (5-GGTTCTTTTTGTCAAGACCGACCTGT) and 391 (5-
CAGTCTAGCTATCGTCATGTAAGCCCACT) were used in combination
with TaqI digestion and religation; primers 395 (5-AAGCTTGCTCAATCA
ATCACC) and 465 (5-CGCCAACTATTGCGATAACA) were used in combi-
nation with HhaI digestion and religation.
Biofilm study. Biofilm formation on polyvinyl chloride (PVC) surfaces was
monitored by using 96-well microtiter plates (Falcon) essentially as described
previously (45). Briefly, cells were grown for 24 h in M9 minimal medium
(containing 0.2% glucose) at 37°C, washed to remove unbound cells and stained
with crystal violet. The quantification of bound cells was performed by the
addition of acetone-ethanol (20:80) and measurement of the dissolved crystal
violet at an optical density of 595 nm (OD595). Flow chamber biofilm experi-
ments were performed as described previously (23, 44), with the exception that
cells were detected by using BacLight green fluorescent stain (Molecular
Probes). Briefly, biofilms were allowed to form on glass surfaces in a multichan-
nel flow system that permitted online monitoring of community structures. Flow
cells were inoculated with OD600-standardized pregrown overnight cultures in
M9 medium. BacLight green fluorescent stain was used at a concentration of 0.1
mM, according to the manufacturer’s instructions. Biofilm development was
monitored by confocal scanning laser microscopy at 20 to 24 h after inoculation.
All experiments were performed in triplicate.
Scanning electron microscopy (SEM). Cells were grown as described for the
biofilm study on polystyrene surfaces, with the exception that the experiment was
performed by using a 12-well microtiter plate (Greiner Bio-One) with a poly-
styrene disc placed at the bottom. The disc was fixed with 3% glutaraldehyde in
0.1 M cacodylate buffer and postfixed with 1% osmium tetroxide in 0.1 M
cacodylate buffer. The sample was then infiltrated with glycerol and frozen in
liquid nitrogen. The sample was freeze-substituted in 100% ethanol containing a
molecular sieve and left at 80°C for 10 h, and then the temperature was
increased from 80°C to 20°C over a 10-h period and critical point dried. The
sample was then mounted on carbon tabs and sputter coated with platinum 15
mA for 120 s.
Phylogenetic analysis. PCR products obtained from screening for the presence
of mrkB were sequenced from 36 strains. Sequences were trimmed to obtain 130
nucleotides of high-quality sequence corresponding to the central region of mrkB
(i.e., nucleotides 179 to 308 of mrkB in K. pneumoniae MGH78578). Phylogenetic
analyses of 36 aligned mrkB sequences were carried out by using PHYLIP (8, 12,
16, 20). Consensus trees of bootstrap analyses were prepared by using the
consensus network method (8, 12, 16, 20) as implemented by SplitsTree, version
4 (8, 12, 16, 20). Evidence for recombination was assessed by using the pairwise
homoplasy index recombination test (8, 12, 16, 20).
Statistical analysis. Differences in comparison of phenotypes from CAUTI E.
coli and E. coli from other UTI syndromes were determined by using a chi-square
test for the differences between two groups. Differences in biofilm phenotypes
(mean optical density values) were compared by using a t test with a linear mixed
model; each microtiter plate well was treated as a random effect, and each gene
TABLE 1. Bacterial strains and plasmids
Strains/plasmids Description Reference
E. coli strains
MS427 K-12 MG1655 flu 39
MS528 K-12 MG1655 fim flu 25
MS661 MS427recA::tet 39
MS1219 E. coli S17-1  pUT(mini-Tn5kan) 30
MS1355 Rifampin resistant MS2027 This study
MS1520 E. coli DH5 containing pCO10 This study
MS1486 MS2027 transconjugant P4-6E
(mrkD::Tn5kan)
This study
MS1488 MS2027 transconjugant P20-5B
(mrkB::Tn5kan)
This study
MS1489 MS2027 transconjugant P20-11A
(mrkA::Tn5kan)
This study
MS1502 MS2027 transconjugant P17-9H
(rmlC::Tn5kan)
This study
MS1505 MS2027 transconjugant P20-11B
(manB::Tn5kan)
This study
MS1506 MS2027 transconjugant P22-3H
(kpsM::Tn5kan)
This study
MS1998 MS528  pCO12 This study
MS2000 MS528  pBR322 (no insert) This study
MS2001 MS1486  pCO12 This study
MS2003 MS1486  pBR322 (no insert) This study
MS2004 MS1488  pCO12 This study
MS2006 MS1488  pBR322 (no insert) This study
MS2007 MS1505  pCO12 This study
MS2009 MS1505  pBR322 (no insert) This study
MS2027 E. coli CAUTI isolate This study
Plasmids
pCO10 Plasmid from MS1486 (mrkD::Tn5kan) This study
pCO12 mrkABCDF amplified from E. coli
MS2027 with primers 871 and 872
and ligated into EcoRV site of
pBR322
This study
pBR322 Cloning vector 63
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modification was treated as a fixed effect. All comparisons were against the
values for E. coli MS2027. Both analyses were performed by using the statistical
analysis program R (36a).
Nucleotide sequence accession numbers. The mrkB sequence fragments from
34 strains were deposited in GenBank under accession numbers EU109428 to
EU109460. The complete 9.3-kb mrk cluster (and adjacent regions) from E. coli
MS2027 was deposited in GenBank under accession number EU105468.
RESULTS
Biofilm formation by CAUTI E. coli strains. Sixty-five
CAUTI E. coli strains from our UTI collection were examined
for the ability to cause MS agglutination of yeast cells, MR
agglutination of human RBC, and biofilm formation. These
phenotypes were compared to those of strains collected from
patients with asymptomatic bacteriuria (ABU), cystitis, and
pyelonephritis from the same geographic location (Table 2).
Sixty-two percent of the CAUTI E. coli strains were positive by
the biofilm assay, while 42% of ABU (P  0.05) and 15% of
pyelonephritis strains were positive (P  0.05). There was no
correlation between biofilm formation and MR agglutination
of human RBC. Biofilm analysis of the 65 CAUTI E. coli
strains revealed a range of phenotypes (Fig. 1). To identify
novel factors associated with biofilm formation by CAUTI E.
coli, we studied strains that exhibited strong biofilm growth for
the expression of type 1 fimbriae (by MS agglutination of yeast
cells) and curli production (by Congo red staining). E. coli
MS2027 was identified as a unique strong biofilm former that
did not express type 1 fimbriae or curli under the growth
conditions employed in this study. We therefore chose E. coli
MS2027 for an in-depth molecular analysis.
Generation of E. coli MS2027 mini-Tn5 mutants altered in
biofilm formation. A collection of approximately 2,000 Kmr
transposon insertion mutants were screened for their ability to
form biofilms. Two types of biofilm mutants were obtained: (i)
mutants displaying an enhanced biofilm phenotype and (ii)
mutants displaying a decreased biofilm phenotype. SEM was
performed to examine the structure of the biofilms produced
by E. coli MS2027 and selected mutants representing each
phenotype (Fig. 2). The enhanced biofilm growth of E. coli
MS1502 and E. coli MS1506 correlated with a more densely
packed arrangement of cells than the growth of E. coli
FIG. 1. Biofilm formation by CAUTI E. coli strains. Strains were grown at 37°C in PVC microtiter plates containing M9 medium (supplemented
with 0.2% glucose) for 16 h under shaking conditions, washed to remove unbound cells, and stained with 0.1% crystal violet. Biofilm formation
was quantified by resuspending adhered cells in ethanol-acetate (80:20) and measuring the absorbance at 595 nm. The results are presented as the
average of eight individual replicates (	 standard deviation [error bars]). An arbitrary cutoff of OD595 at 0.5 was used, and strains were scored as
either positive or negative for biofilm formation. The black bar highlights E. coli MS2027.
TABLE 2. Comparison of phenotypes from CAUTI E. coli and E. coli from other UTIs
Source of isolates
Value for phenotypea
MS agglutination MR agglutination Biofilm
No. of isolates (%) PR P No. of isolates (%) PR P No. of isolates (%) PR P
CAUTI (n  65) 54 (83) 10 (15%) 40 (62%)
Pyelonephritis (n  26) 24 (92) 1.11 0.42 13 (50%) 3.33 0.00 4 (15%) 0.24 0.00
Cystitis (n  19) 19 (100) 1.20 0.12 5 (26%) 1.73 0.45 8 (42%) 0.68 0.21
ABU (n  57) 42 (74) 0.89 0.30 14 (25%) 1.67 0.30 24 (42%) 0.68 0.05
a Where the prevalence ratios (PR) and P values are relative to CAUTI isolates.
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MS2027. In contrast, cells from the biofilm-deficient mutant E.
coli MS1486 were virtually undetectable. All of the mutants
exhibited a growth rate indistinguishable from that of the wild-
type strain (data not shown).
The insertion site of each mutant was determined by inverse
PCR. The sequencing of the DNA flanking the transposon
insertion site for the mutants displaying the enhanced biofilm
phenotype (i.e., MS1502, MS1505, and MS1506) revealed that
the transposon insertions disrupted genes associated with O
antigen or capsule production (Table 3). In the case for the
mutants displaying the decreased biofilm phenotype (i.e.,
MS1486, MS1488, and MS1489), all of the transposon inser-
tions disrupted the same genetic locus, but at different posi-
tions. Blast analysis revealed that this genetic locus was homol-
ogous to the mrk (type 3 fimbriae) genetic locus of K.
pneumoniae (Table 3). Unlike the E. coli MS2027 parent
strain, all of these mutants were unable to exhibit MR/K ag-
glutination, a standard assay for monitoring the expression of
type 3 fimbriae in K. pneumoniae.
The E. coli mrk gene locus is carried on a conjugative plas-
mid. E. coli MS2027 contains several plasmids, and we sus-
pected that the mrk genes were located on one of these. Thus,
we attempted to transfer the mrk genes (containing Tn5-kana-
mycin) from the Tn5 mutants MS1486, MS1488, and MS1489
into a tetracycline-resistant E. coli MG1655 derivative strain
(MS661) via conjugation. Indeed, we were able to obtain
kanamycin-resistant E. coli MS661 transconjugants using all
three Tn5 mutants by this method. PCR using primers specific
for the mrk sequence identified previously by inverse PCR
demonstrated that the mrk genes were located on this conju-
gative plasmid. The plasmid that originated from E. coli
MS1486 was designated pCO10.
Characterization of the E. coli mrk gene locus. The mrk locus
was sequenced directly from pCO10 on both DNA strands by
primer walking. The sequence of the region disrupted by the
Tn5 insertion was confirmed by PCR and sequencing from
the intact plasmid in E. coli MS2027 (designated pMS2027).
The mrk gene cluster contains six open reading frames (ORFs)
arranged in the same transcriptional orientation, including
genes that encode a putative major subunit protein (mrkA) as
well as putative chaperone (mrkB)-, usher (mrkC)-, adhesin
(mrkD)-, and anchor (mrkF)-encoding genes (Fig. 3). The E.
coli mrk locus does not contain a putative regulator gene
(mrkE) upstream of mrkA, unlike the K. pneumoniae mrk lo-
cus. Instead, this DNA sequence has a mosaic structure. The
nucleotide sequence immediately upstream of mrkA is 98%
FIG. 2. SEM micrographs depicting the biofilm structures of E. coli MS2027 and representative Tn5 mutants. (A) E. coli MS2027, (B) E. coli
MS1486 (MS2027 mrkD::Tn5kan), (C) E. coli MS2001 (MS1486 complemented with pCO12), (D) MS1502 (MS2027 rmlC::Tn5kan), and
(E) MS1506 (MS2027 kpsM::Tn5kan). Cells were grown in 12-well microtiter plates (Greiner Bio-One) containing a polystyrene disc placed at the
bottom. Following overnight growth, the disc was removed, fixed, stained, and examined by SEM as described in Materials and Methods. Scale bar,
10 m.
TABLE 3. Transposon mutagenesis results for strain
E. coli MS2027
Strain Biofilmtype
Gene
disrupted Gene function
MS1486 Reduced mrkD Adhesin of type 3 fimbriae
MS1488 Reduced mrkB Chaperone of type 3 fimbriae
MS1489 Reduced mrkA Major subunit of type 3 fimbriae
MS1502 Increased rmlC dTDP-4-dehydrorhamnose 3,5-
epimerase of OAg gene cluster
MS1505 Increased manB Phosphomannomutase of OAg
gene cluster
MS1506 Increased kpsM Polysialic acid transport protein,
membrane component
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identical (771/781 nucleotides) to the region spanning nucleo-
tides 3116637 to 3117411 of the K. pneumoniae MGH78578
genome. This region contains genes encoding a putative IS1
transposase (KPN_02838) and an insertion element protein
(KPN_02839). Further upstream we identified two putative
ORFs (c4509 and c4510) that are highly similar to hypothetical
genes found on the UPEC CFT073 chromosome (this region
shares 96% [2010 of 2081] nucleotide sequence similarity with
the corresponding region from CFT073). Downstream of
mrkF, we identified an ORF (orf1) that encodes a putative
cytoplasmic protein from Salmonella enterica SC-B67 (93%
[296 of 315] nucleotide sequence similarity). The mrk gene
cluster from E. coli MS2027 has an overall GC content of
56.6%, which is closer to that found in K. pneumoniae
MGH78578 (57.5%) than to that found in E. coli K-12
(50.8%). The nucleotide sequence similarity of each mrk gene
(and the amino acid identity of its product) to the correspond-
ing sequence from K. pneumoniae pIA565 (gb M55912) and K.
pneumoniae MGH78578 (gb CP000647) is shown in Table 4.
The mrk locus promotes biofilm formation. The mrk locus
was amplified by PCR from E. coli MS2027 and cloned into the
EcoRV site of pBR322 to generate plasmid pCO12. When this
plasmid was introduced into E. coli MS528 (an MG1655 fim flu
strain deficient in biofilm formation), we observed strong bio-
film growth (Fig. 4). Biofilm formation was observed in static
and dynamic growth conditions in M9 minimal medium (but
not in LB broth). Plasmid pCO12 was also transformed into
the three Tn5 mutants deficient in biofilm formation. The
introduction of pCO12 into these strains restored their ability
to form biofilms (Fig. 4), which was also confirmed by SEM
(Fig. 2E).
We next employed a continuous flow chamber system to
examine the ability of type 3 fimbriae to promote biofilm for-
mation by E. coli in dynamic conditions. Consistent with the
results of our microtiter plate biofilm assays, E. coli MS2027
produced a strong biofilm (with a depth of approximately 10
m), while E. coli MS2003 (mrkD::Tn5) was unable to form a
biofilm (Fig. 5). The defect in biofilm growth by E. coli MS2003
could be complemented by the addition of plasmid pCO12
(which contains the mrk gene cluster from E. coli MS2027).
Thus, type 3 fimbriae can promote strong biofilm growth by E.
coli in two distinct in vitro model systems.
Type 3 fimbrial expression is not associated with coloniza-
tion of the mouse urinary tract. E. coli MS2027 and the mrkD
mutant MS1486 were tested for their ability to colonize and
survive in the mouse urinary tract. We did not observe any
significant difference in the ability of either strain to colonize
the mouse bladder following transurethral infection. We also
tested these two strains in a competition challenge experiment
using a 50:50 mixture of each strain as the inoculum. However,
no difference in colonization of the bladder was observed (data
not shown). Neither strain was isolated from the mouse kidney
at the time points assayed.
Distribution of mrk genes in UPEC and other UTI patho-
gens. The finding that the mrk genes were located on a conju-
gative plasmid in E. coli prompted us to test for the prevalence
of these genes in UPEC and other CAUTI pathogens. Primers
were designed to PCR amplify an internal segment of the mrkB
gene. First we tested for the presence of mrkB in the remaining
64 CAUTI E. coli strains from our collection. Two of these
strains had positive PCR results and were confirmed by DNA
FIG. 3. Physical map of the mrk gene cluster and adjacent regions from E. coli MS2027, K. pneumoniae IA565, and K. pneumoniae MGH78578.
The mrk genes are indicated and include mrkE (putative regulatory gene), mrkA (major subunit encoding gene), mrkB (chaperone encoding gene),
mrkC (usher encoding gene), mrkD (adhesin encoding gene), and mrkF (encoding a putative anchor protein). The mrk genes from E. coli MS2027
and K. pneumoniae IA565 are plasmid located, while the mrk genes from K. pneumoniae MGH78578 are chromosomally located. ORFs adjacent
to the mrk genes from both E. coli MS2027 and K. pneumoniae MGH78578 are also shown. E. coli MS2027-adjacent ORFs were KPN_02838
(encodes a putative IS1 transposase from K. pneumoniae MGH78578), KPN_02839 (encodes a putative insertion element protein from K.
pneumoniae MGH78578), orf3 (encodes a putative cytoplasmic protein), and c4510 and c4509 (encode putative hypothetical proteins from E. coli
UPEC CFT073). K. pneumoniae MGH78578-adjacent ORFs were marR (encodes a putative regulatory protein) and KPN_03281 and KPN_03274
(encode hypothetical proteins). Sequence information outside the mrk cluster is not known for K. pneumoniae IA565. Arrows indicate the direction
of transcription for each gene.
TABLE 4. Comparison of the E. coli MS2027 Mrk protein and
nucleotide sequences with the corresponding sequences
from K. pneumoniae IA565(pIA565) and
K. pneumoniae MGH78578
Mrk
protein
Putative
function
% Amino acid identity (nucleotide sequence
conservation) of indicated protein in
K. pneumoniae strain
IA565 plasmid-
encoded Mrk
MGH78578 chromosome-
encoded Mrk
MrkA Major subunit 90 (86) 94 (99)
MrkB Chaperone 91 (83) 100 (99)
MrkC Usher 87 (82) 99 (99)
MrkD Adhesin 54 (81) 97 (98)
MrkF Anchor 78 (76) 99 (99)
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sequencing. Next, we tested for the presence of mrkB in 70
CAUTI pathogens representing different gram-negative organ-
isms isolated from UTI patients from the same location (Table
5). The mrk genes were detected from K. pneumoniae, K.
oxytoca, C. koseri, and C. freundii CAUTI isolates (Table 5).
The identity of each PCR product was confirmed by DNA
sequencing. To determine whether the presence of the mrk
genes was specific to CAUTI strains, we also tested for their
prevalence in 45 E. coli strains isolated from cystitis and py-
elonephritis patients. Among these strains, 2 of 45 contained
the mrkB gene as determined by PCR amplification and DNA
sequencing. Finally, we tested for the prevalence of mrkB in
strains from the ECOR collection; three strains had positive
PCR products for these genes, with results confirmed as cor-
rect by DNA sequencing. All of the organisms that contained
the mrkB gene displayed a positive MR/K agglutination phe-
notype following growth in M9 minimal medium. We note that
the C. koseri and C. freundii strains required growth in M9
FIG. 4. (A) Biofilm formation by E. coli MS2027 and derivatives. Strains were grown at 37°C in PVC microtiter plates containing M9 medium
(supplemented with 0.2% glucose) for 16 h under shaking conditions, washed to remove unbound cells, and stained with 0.1% crystal violet. Biofilm
formation was quantified by resuspending adhered cells in ethanol-acetate (80:20) and measuring the absorbance at 595 nm. The results are
presented as the average of eight individual replicates (	 standard deviation). Shown are the results for MS1486 (MS2027 mrkD::Tn5kan), MS1488
(MS2027 mrkB::Tn5kan), MS1489 (MS2027 mrkA::Tn5kan), MS2003, MS2006, and MS2009, mrk mutants containing pBR322; MS2001, MS2004, and
MS2007, mrk mutants containing pCO12 (mrk); MS1502 (rmlC mutant); MS1505 (manB mutant); and MS1506 (kpsM mutant). (B) Biofilm formation
by E. coli MS528 and E. coli MS528 containing pCO12. Cells were grown and analyzed for biofilm formation as described above. The introduction of
plasmid pCO12 (containing the mrk gene cluster from MS2027) into MS528 promoted strong biofilm growth. , absence of; , presence of.
FIG. 5. Flow chamber biofilm formation of E. coli MS2027 (A), E.
coli MS2003 (B), and E. coli MS2001 (C). Biofilm development was
monitored by confocal scanning laser microscopy 24 h after inocula-
tion. Micrographs represent horizontal sections. Depicted to the right
and below are vertical sections through the biofilm collected at the
positions indicated by the lines.
TABLE 5. Prevalence of mrkB gene and MR/K agglutination
phenotype among UTI strains
Bacterial species
and strain type
Total no. of
strains
Presencea of:
mrkB MR/KHA
Escherichia coli
CAUTI 93 3 (3.2) 3 (3.2)
ABU 23 0 (0) 0 (0)
Cystitis 19 1 (5.3) 1 (5.3)
Pyelonephritis 26 1 (3.8) 1 (3.8)
ECOR 72 3 (4.2) 3 (4.2)
Other species
C. freundii 7 1 (14.3) 1 (14.3)
C. koseri 9 9 (100) 9 (100)
K. oxytoca 2 2 (100) 2 (100)
K. pneumoniae 15 13 (86.7) 13 (86.7)
a Values are shown as no. (%).
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minimal medium for 72 h under static conditions to induce
MR/K agglutination.
Comparison of mrkB DNA sequences from different UTI
pathogens. An unrooted maximum likelihood DNA phylogram
was constructed from 36 aligned mrkB gene fragments (130
nucleotides in length, comprising 35 polymorphic sites, 28 of
which were informative). A consensus network tree of 1,000
bootstrap replicates revealed five distinct groups, ranging from
20 members (represented by K. pneumoniae MG78758) to one
member (C. freundii) (Fig. 6). The most common primary
allele is found in both E. coli and K. pneumoniae (e.g., E. coli
MS2039 and Klebsiella pneumoniae MGH78578 mrkB se-
quences are identical). Furthermore, two E. coli mrkB se-
quences (M184 and ECOR28) are identical to the plasmid-
borne Klebsiella pneumoniae pIA565 mrkB, which shares only
85% nucleotide identity with mrkB from strain MGH78578.
These observations strongly suggest lateral gene transfer of
mrkB in E. coli and K. pneumoniae. Comparisons of full-length
mrkA and mrkC sequences from K. pneumoniae IA565 and
MGH78578 with E. coli MS2027 show similar levels of diver-
gence to that observed for mrkB (Table 4). This result suggests
that the mrkB phylogenetic tree is representative of mrkA and
mrkC and that en bloc transfer of the mrk cluster has occurred.
The long internal branches represent the divergence of pri-
mary mrkB alleles (Fig. 6), with an average interallelic nucle-
otide diversity of 9.8%. Secondary variant types are observed
only within the KpMGH78578 and C. koseri groups (1% and
1.8% intra-allelic nucleotide diversity, respectively). No statis-
tically significant evidence of recombination was detected be-
tween groups according to the pairwise homoplasy index test
(8, 12, 16, 20). According to the consensus network (Fig. 6),
there is some incompatibility in the divergence of C. koseri
clones (as indicated by more than one branch leading to the
CkM7/CkM8 tip); however, there are too few informative sites
(n  3) to accurately discriminate recombination from recur-
rent mutation among this group. Tree topologies very similar
to those obtained by using DNA maximum likelihood were
obtained by using parsimony- and distance-based phylogenetic
methods (data not shown).
DISCUSSION
CAUTI is associated with biofilm formation on the inner
surfaces of indwelling catheters. E. coli is a major cause of
CAUTI, and several surface factors that contribute to biofilm
growth by E. coli have been characterized. Type 1 fimbria
expression is associated with persistence in the long-term-cath-
eterized urinary tract (29), and minor modifications in the
FimH adhesin can enhance biofilm formation (45). Flagella
are motility organelles that play a role in the initial adhesion
phase of biofilm formation (36). Curli are thin aggregative
fibers involved in bacterial attachment and biofilm formation
(38). In many E. coli strains, the expression of curli is temper-
ature sensitive and occurs at 28°C but not at 37°C. Antigen 43
(Ag43) is a self-recognizing autotransporter adhesin that is
associated with cell aggregation, biofilm formation, and uro-
virulence (6, 24, 54). Other factors that promote biofilm
growth by E. coli include conjugative pili (14, 37) and several
recently described cryptic autotransporter proteins (39). In this
study, we have demonstrated that genes involved in capsule
synthesis, O antigen production, and type 3 fimbriae influence
biofilm formation by the CAUTI E. coli strain MS2027.
Three Tn5 mutants of E. coli MS2027 that possessed an
increased biofilm formation phenotype were identified. The
Tn5 insertions resulted in the disruption of genes associated
with O antigen synthesis (rmlC and manB) and capsule syn-
thesis (kpsM). Capsular polysaccharides are produced by many
uropathogenic bacteria and provide protection from host cell
phagocytosis. Capsular polysaccharides also contribute to
UPEC biofilm formation in the bladder (6, 11). The enhanced
biofilm growth of E. coli MS1506 might at first sight appear
contradictory to these comments. However, our observations
may reflect the limitations of the microtiter plate biofilm assay
in comparison to in vivo biofilm growth. E. coli MS1506 con-
tained a Tn5 insertion in the kpsM gene, which encodes an
integral membrane protein involved in the translocation of the
polysialic capsule. Previous studies have shown that an E. coli
kpsM mutant is defective in capsule synthesis (35). While we
have not shown that MS1506 is defective in capsule produc-
tion, it is tempting to speculate that its enhanced biofilm
growth is associated with the unmasking of other adhesins. In
support of this hypothesis, a recent study reported that the
expression of the nonfimbrial adhesin Ag43 in unencapsulated
Klebsiella strains results in enhanced biofilm growth compared
to capsulated strains that express Ag43, suggesting that the
capsule might block the activity of other surface-located ad-
hesins (43). The capsule shielding effect has also been demon-
FIG. 6. Unrooted phylogram of type 3 family chaperone genes
(mrkB). Branch confidence levels are indicated by line thickness: thick,

90%; thin, 
50%; dashed, 50%. Confidence levels were deter-
mined from 1,000 bootstrap replicates of DNA maximum likelihood
trees prepared by using PHYLIP DNAML (8, 12, 16, 20). A network
of all 1,000 trees was prepared by using the consensus network method
(8, 12, 16, 20), as implemented by SplitsTree, version 4 (8, 12, 16, 20).
Taxon IDs include species name abbreviations as suffixes (Ec, E. coli;
Cf, C. freundii; Ck, C. koseri; Ko, K. oxytoca; and Kp, K. pneumoniae),
followed by a unique strain identifier. The major group containing E.
coli MS2027 and K. pneumoniae MGH78578 (shown in bold) is circled
for greater clarity. K. pneumoniae IA565 is also shown in bold.
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strated in adherence studies of other organisms, including E.
coli (40, 43), Neisseria meningitidis (56), and Haemophilus in-
fluenzae (50). Furthermore, the function of type 1 fimbriae has
been shown to be impeded by the presence of a capsule on the
bacterial cell surface (42) and thus reduced capsule synthesis
by E. coli MS1506 may enhance the contribution of fimbriae to
biofilm formation. We note that soluble polysaccharide se-
creted by UPEC strains that produce a group II capsule was
recently shown to inhibit biofilm growth by preventing adhe-
sion (55). Therefore, we cannot rule out the possibility that the
enhanced biofilm growth of MS1506 is due to reduced secre-
tion of antiadhesive polysaccharide material. The enhanced
biofilm growth by E. coli MS1508 and E. coli MS1509 might be
associated with a similar mechanism, since many UPEC strains
are known to produce large O antigen structures. We are
currently attempting to elucidate the role of the capsule and O
antigen in UPEC colonization and biofilm formation in an in
vivo model of CAUTI.
The decreased biofilm growth by Tn5 mutants of E. coli
MS2027 was due to the disruption of genes encoding type 3
fimbriae. Three biofilm-deficient mutants were identified, all of
which contained a Tn5 insertion in the mrk operon. The role of
type 3 fimbriae in biofilm formation was confirmed by the
complementation of each of these mutants with a plasmid
(pCO12) containing the mrk genes. Type 3 fimbriae are thin,
filamentous structures (4 to 5 nm wide and 0.5 to 2 m long)
that extend from the surface of the cell (10) and are morpho-
logically similar to K88 and K99 fimbriae (26). Type 3 fimbriae
are characterized by their ability to mediate MR agglutination
of tannic acid-treated RBC (which is referred to as MR Kleb-
siella-like or MR/K agglutination) (26). MR/K agglutination is
conferred by the MrkD adhesin (5, 19). MrkD also mediates
binding to the basolateral surface of renal tubular, tracheal,
and bronchial cells via a high-affinity interaction with type V
collagen (17, 51, 52). Type 3 fimbriae from K. pneumoniae have
also been shown to mediate biofilm formation (21).
Type 3 fimbriae are most commonly associated with Kleb-
siella spp. (13). However, they are also produced by other
members of the Enterobacteriaceae family, including Entero-
bacter, Morganella, Proteus, Providencia, Serratia, Salmonella,
and Yersinia species (1–4, 13, 30–33, 48). Here we demonstrate
that type 3 fimbriae are also produced by E. coli, C. koseri, and
C. freundii. In E. coli MS2027, the mrk genes are located on a
conjugative plasmid of approximately 45 kb (C.-L. Y. Ong,
A. G. McEwan, and M. A. Schembri, unpublished data). Plas-
mid-carried mrk genes have previously been identified for K.
pneumoniae and Y. enterocolitica (5, 13). K. pneumoniae IA565
possesses both chromosomal and plasmid-carried mrk genes;
the plasmid pIA565 contains a functional copy of mrkA and
mrkD, while only mrkA has been detected on the K. pneu-
moniae IA565 chromosome. The mrk genes from pIA565 have
been well characterized and possess the same genetic arrange-
ment as do the mrk genes on plasmid pMS2027. However, the
sequence upstream of mrkA is different between the two gene
clusters (the sequence downstream of mrkF on pIA565 has not
been reported). On plasmid pIA565, a gene (mrkE) encoding
a putative regulator protein is located immediately upstream of
mrkA (5). This gene is not present on pMS2027. Instead, we
identified a putative transposase-encoding gene upstream of
mrkA and the entire cluster is flanked by two putative insertion
sequence elements. Thus, it seems likely that the mrk cluster
on plasmid pMS2027 is associated with a mobile genetic ele-
ment. Importantly, the presence of mrk genes in E. coli was not
unique to strains in our UTI collection, as three strains from
the ECOR collection also contained mrkABC and caused
MR/K hemagglutination. The location of the mrk genes from
these strains remains to be determined.
We observed that the expression of type 3 fimbriae was
dependent on the growth medium. E. coli MS2027 produced a
strong biofilm and caused characteristic MR/K agglutination
when grown in M9 minimal medium supplemented with glu-
cose but not when grown in LB medium. This finding is con-
sistent with the results of previous reports of type 3 fimbria
expression in K. pneumoniae, where bacteria grown in minimal
medium in the presence of glycerol or glucose resulted in a
stronger MR/K hemagglutination reaction than did bacteria
grown in complex medium (18, 47). This result suggests a
similar method of regulation of the type 3 fimbrial genes of K.
pneumoniae IA565 and E. coli MS2027, despite the absence of
the putative mrkE regulator gene on pMS2027. It is interesting
that all of the mrkABC-positive strains identified in this study
caused MR/K agglutination, since previous studies have shown
that not all Klebsiella spp. possess the adhesin-encoding mrkD
gene (19).
We compared the mrk cluster from E. coli MS2027 with the
mrk clusters from K. pneumoniae MGH78578 and pIA565 (Ta-
ble 4). All five mrkABCDE genes showed remarkable sequence
similarity to the chromosomally located MGH78578 sequences
(98.8% 	 0.4%) compared to that shown by the respective
pIA565 sequences (81.6% 	 3.6%). The presence of insertion
sequences adjacent to the plasmid-borne E. coli MS2027 mrk
cluster and the GC content suggest that there was relatively
recent lateral transfer from a K. pneumoniae strain, although
we cannot rule out the possibility that both strains acquired the
cluster independently from a third species. To assess the dis-
tribution of this cluster among UTI organisms, we amplified
and sequenced a fragment of the chaperone gene (mrkB),
which is typically the most highly conserved gene within chap-
erone/usher fimbrial clusters. Phylogenetic analyses indicated
there were five primary alleles which, with the exception of the
two K. oxytoca strains, are strongly supported by long internal
branches (Fig. 6). The most common allele is that shared by K.
pneumoniae MGH78578 and E. coli MS2027. This allele is also
shared by E. coli CAUTI strains MS2039 and M148 and cystitis
strain M202. Interestingly, mrkB from the pyelonephritis E.
coli strain M184 is identical to that found in K. pneumoniae
pIA565. The observation that two alleles (represented by
strains MGH78578 and IA565) contain sequences that are
identical in both E. coli and K. pneumoniae species, but sub-
stantially divergent from each other, is strong evidence of re-
current and recent lateral gene transfer of the mrk cluster
among K. pneumoniae and E. coli UTI strains.
In conclusion, we have identified the capsule, O antigen, and
type 3 fimbriae as factors that affect biofilm growth by CAUTI
E. coli. Type 3 fimbriae are produced by many members of the
Enterobacteriaceae family that are associated with opportunis-
tic infections. Biofilm growth mediated by type 3 fimbriae may
be important for the survival of these organisms on the sur-
faces of urinary catheters and within the hospital environment.
We speculate that the mrk gene cluster in E. coli MS2027 may
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have originated from K. pneumoniae, and we are currently
investigating this possibility.
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